Inventor · disambiguated record
Frederic Lallemand
Also filed as: LALLEMAND FREDERIC · LALLEMAND FRÉDÉRIC
20 granted patents·17 pending applications·20 citations·filing 2006–2024
91Inventor score
Top patents by PatentIndex Score
37 records- 0184US12156854B2Topical pharmaceutical composition in the form of aqueous gel comprising at least amitriptylineALGOTHERAPEUTIX·Filed 2024·Granted Dec 3, 2024·1 cites·20 claims
- 0281US2023181738A1Oil-in-water emulsions comprising cetalkonium chloride and methods of making and using the sameSANTEN SAS·Filed 2023·Application pending·0 cites
- 0379US9682147B2Self-preserved oil dispersions comprising boric acidSANTEN SAS·Filed 2013·Granted Jun 20, 2017·2 cites·14 claims
- 0475US12150920B2Topical pharmaceutical composition in the form of aqueous gel comprising at least amitriptylineALGOTHERAPEUTIX·Filed 2024·Granted Nov 26, 2024·0 cites·11 claims
- 0575US9555045B2Use of prostaglandins F2alpha and analogues for the healing of corneal and conjunctival lesionsGARRIGUE JEAN-SEBASTIEN·Filed 2010·Granted Jan 31, 2017·6 cites·14 claims
- 0674US11612658B2Oil-in-water emulsions comprising cetalkonium chloride and methods of making and using the sameSANTEN SAS·Filed 2020·Granted Mar 28, 2023·0 cites·20 claims
- 0773US7973081B2Emulsion compositions containing quaternary ammonium compoundsNOVAGALI PHARMA SA·Filed 2007·Granted Jul 5, 2011·1 cites·9 claims
- 0870US10842873B2Methods for preparing oil-in-water emulsions comprising cetalkonium chlorideSANTEN SAS·Filed 2018·Granted Nov 24, 2020·0 cites·26 claims
- 0970US8512687B2Oil in water emulsion comprising NSAIDs and quaternary ammonium halidesLAMBERT GREGORY·Filed 2010·Granted Aug 20, 2013·2 cites·23 claims
- 1069US9364461B2Process for manufacturing ophthalmic oil-in-water emulsionsLAMBERT GREGORY·Filed 2007·Granted Jun 14, 2016·3 cites·25 claims
- 1169US9072750B2Use of prostaglandins F2Alpha and analogues for the healing of corneal and conjunctival lesionsGARRIGUE JEAN-SÉBASTIEN·Filed 2010·Granted Jul 7, 2015·3 cites·18 claims
- 1267US9132071B2Compositions containing quaternary ammonium compoundsRABINOVICH-GUILATT LAURA·Filed 2008·Granted Sep 15, 2015·0 cites·19 claims
- 1367US8071114B2Compositions containing quaternary ammonium compoundsRABINOVICH-GUILATT LAURA·Filed 2007·Granted Dec 6, 2011·0 cites·17 claims
- 1466US8524779B2Emulsion compositions containing quaternary ammonium compoundsRABINOVICH-GUILATTI LAURA·Filed 2011·Granted Sep 3, 2013·1 cites·19 claims
- 1565US2025230208A1Methods for treating eye diseases using lipid binding protein-based complexesABIONYX PHARMA SA·Filed 2023·Application pending·0 cites
- 1664US9220694B2Emulsion compositions containing cetalkonium chlorideNOVAGALI PHARMA SA·Filed 2013·Granted Dec 29, 2015·0 cites·18 claims
- 1761US2008026013A1Compositions containing quaternary ammonium compoundsRABINOVICH-GUILATT LAURA·Filed 2006·Application pending·0 cites
- 1860US9956289B2Emulsion compositions containing quaternary ammonium compoundsSANTEN SAS·Filed 2015·Granted May 1, 2018·0 cites·19 claims
- 1958US2022304949A1Topical pharmaceutical composition in the form of aqueous gel comprising at least amitriptylineALGOTHERAPEUTIX·Filed 2021·Application pending·0 cites
- 2057US9616016B2Method for treating retinal conditions using an intraocular tamponadeLALLEMAND FRÉDÉRIC·Filed 2010·Granted Apr 11, 2017·1 cites·17 claims
- 2157US2009170944A1Ophthalmic micellar compositions with enhanced stabilityNOVAGALI PHARMA SA·Filed 2008·Application pending·0 cites
- 2256US7834172B2Composition comprising at least one nucleosidic moiety as a therapeutic agent, and CKCNOVAGALI PHARMA SA·Filed 2007·Granted Nov 16, 2010·0 cites·18 claims
- 2355US2022387594A1Use of amitriptyline and/or one of the pharmaceutically acceptable salts thereof as a preservativeALGOTHERAPEUTIX·Filed 2022·Application pending·0 cites
- 2455US2009018057A1OIL IN WATER EMULSION COMPRISING NSAIDs AND QUATERNARY AMMONIUM HALIDESLAMBERT GREGORY·Filed 2007·Application pending·0 cites
- 2554US2024335375A1Mucoadhesive ocular delivery system for the treatment of glaucomaBIOADHESIVE OPHTHALMICS·Filed 2022·Application pending·0 cites
- 2653US2023103462A1Topical pharmaceutical composition in gel form comprising at least amitriptyline for use in the treatment of neuropathic phantom limb painALGOTHERAPEUTIX·Filed 2022·Application pending·0 cites
- 2753US2023103300A1Topical pharmaceutical composition in gel form comprising at least amitriptyline for use in the treatment of coronavirus-induced neuropathic painALGOTHERAPEUTIX·Filed 2022·Application pending·0 cites
- 2852US2024041766A1Topical pharmaceutical composition comprising amitriptyline and an alkaline aqueous phaseALGOTHERAPEUTIX·Filed 2022·Application pending·0 cites
- 2950US2024000948A1Methods for treating eye diseases using lipid binding protein-based complexesABIONYX PHARMA SA·Filed 2021·Application pending·0 cites
- 3048US2024299378A1Emulsion for use in the treatment of rosaceaEXINOV·Filed 2022·Application pending·0 cites
- 3146US2009169629A1Micellar compositions with ophthalmic applicationsNOVAGALI PHARMA SA·Filed 2008·Application pending·0 cites
- 3245US8623852B2Topical methods and compositions for the treatment of eye diseases and conditionsLAMBERT GREGORY·Filed 2008·Granted Jan 7, 2014·0 cites·9 claims
- 3343US9107822B2Water-in oil type emulsion for treating a disease of the eyeLALLEMAND FREDERIC·Filed 2011·Granted Aug 18, 2015·0 cites·15 claims
- 3441US2012058187A1Water-in-oil type emulsion for treating a disease of the eyeLALLEMAND FREDERIC·Filed 2010·Application pending·0 cites
- 3539US2017165368A1Method for treating retinal conditions using an intraocular tamponadeSANTEN SAS·Filed 2017·Application pending·0 cites
- 3635US2011313038A1Cationic oil-in-water emulsions containing prostaglandins and uses thereofLALLEMAND FREDERIC·Filed 2010·Application pending·0 cites
- 3729US9089480B2Anionic oil-in-water emulsions containing prostaglandins and uses thereofLALLEMAND FREDERIC·Filed 2010·Granted Jul 28, 2015·0 cites·15 claims
Join the waitlist — get patent alerts
Get an alert when Frederic Lallemand files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →